Agenus shares soar after cancer therapy deal with Gilead
Shares of Agenus Inc surged as much as 70 percent on Thursday after the company said it would develop and market up to five of its immuno-oncology therapies in partnership with Gilead Sciences Inc.
No comments:
Post a Comment